Ginkgo biloba versus placebo for schizophrenia

Hongyong Deng; Ji Xu; Wing Fai Yeung

doi:10.1002/14651858.CD012524

Ginkgo biloba versus placebo for schizophrenia

Hongyong Deng, Ji Xu, Wing Fai Yeung

Research output: Journal article publication › Journal article › Academic research › peer-review

2 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of Ginkgo biloba (or its extractions) for people with schizophrenia or related disorders compared with placebo for outcomes of clinical importance.

Original language	English
Article number	CD012524
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	1
DOIs	https://doi.org/10.1002/14651858.CD012524
Publication status	Published - 22 Jan 2017

ASJC Scopus subject areas

Pharmacology (medical)

More information

10.1002/14651858.CD012524

Cite this

@article{65068f61ac7f410d85ecb5dfb8dda0ff,

title = "Ginkgo biloba versus placebo for schizophrenia",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of Ginkgo biloba (or its extractions) for people with schizophrenia or related disorders compared with placebo for outcomes of clinical importance.",

author = "Hongyong Deng and Ji Xu and Yeung, {Wing Fai}",

year = "2017",

month = jan,

day = "22",

doi = "10.1002/14651858.CD012524",

language = "English",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Ginkgo biloba versus placebo for schizophrenia

AU - Deng, Hongyong

AU - Xu, Ji

AU - Yeung, Wing Fai

PY - 2017/1/22

Y1 - 2017/1/22

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of Ginkgo biloba (or its extractions) for people with schizophrenia or related disorders compared with placebo for outcomes of clinical importance.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of Ginkgo biloba (or its extractions) for people with schizophrenia or related disorders compared with placebo for outcomes of clinical importance.

UR - http://www.scopus.com/inward/record.url?scp=85011068487&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012524

DO - 10.1002/14651858.CD012524

M3 - Journal article

SN - 1361-6137

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

M1 - CD012524

ER -

Ginkgo biloba versus placebo for schizophrenia

Abstract

ASJC Scopus subject areas

More information

Other files and links

Fingerprint

Cite this